115 related articles for article (PubMed ID: 394379)
1. Advances in cancer management--an essay on the application of basic science principles.
Costanzi JJ
Tex Rep Biol Med; 1979; 38():79-85. PubMed ID: 394379
[No Abstract] [Full Text] [Related]
2. New targets for cancer chemotherapy.
Arbuck SG; Dancey J; Pluda JM; Grochow L; Murgo AJ; Ivy P; Wright J; Blaylock B; Via LE; Sausville EA
Cancer Chemother Biol Response Modif; 2001; 19():237-88. PubMed ID: 11686017
[No Abstract] [Full Text] [Related]
3. Ifosfamide in non-small cell lung cancer.
Johnson DH
Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of solid tumours.
World Health Organ Tech Rep Ser; 1977; (605):1-106. PubMed ID: 407727
[No Abstract] [Full Text] [Related]
5. [Clonogenic cells in human tumors and the sensitivity to chemotherapy].
Potapov SL; Korman DB
Eksp Onkol; 1986; 8(1):7-12. PubMed ID: 3512239
[TBL] [Abstract][Full Text] [Related]
6. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
Pratt CB
Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
[TBL] [Abstract][Full Text] [Related]
7. Biological response modifiers.
Clark JW
Cancer Chemother Biol Response Modif; 1988; 10():434-59. PubMed ID: 3079394
[No Abstract] [Full Text] [Related]
8. A critical appraisal of the "human tumor stem-cell assay".
Selby P; Buick RN; Tannock I
N Engl J Med; 1983 Jan; 308(3):129-34. PubMed ID: 6336820
[No Abstract] [Full Text] [Related]
9. [Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
Hoefer H; Scheef W; Titscher R; Kokron O
Osterr Z Onkol; 1974; (1):3-7. PubMed ID: 4619650
[No Abstract] [Full Text] [Related]
10. Rationale of combination chemotherapy based on preclinical experiments.
Goldin A
Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
[No Abstract] [Full Text] [Related]
11. Ifosfamide in the treatment of non-small cell lung cancer.
Ettinger DS
Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.
Senderowicz AM
Cancer Chemother Biol Response Modif; 2001; 19():165-88. PubMed ID: 11686013
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy guidelines in human cancer].
Kwaśniewska-Rokicińska C
Postepy Hig Med Dosw; 1976; 30(1):93-120. PubMed ID: 768945
[No Abstract] [Full Text] [Related]
15. Making sense of cancer chemotherapy.
Holmes S
Nurs Times; 1996 Sep 4-10; 92(36):42-3. PubMed ID: 8868768
[TBL] [Abstract][Full Text] [Related]
16. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
17. Advances in the chemotherapy and immunotherapy of lung cancer.
Panettiere FJ; Constanzi JJ
Tex Med; 1979 Feb; 75(2):95-7. PubMed ID: 441969
[No Abstract] [Full Text] [Related]
18. The role of ifosfamide in germ cell tumors and small cell lung cancer.
Nichols CR
Semin Oncol; 1995 Jun; 22(3 Suppl 7):13-7. PubMed ID: 7610394
[TBL] [Abstract][Full Text] [Related]
19. [Overview on chemotherapy of cancer: discussion].
Koyama Y; Ota K; Ogawa K; Saito T; Taguchi T
Gan To Kagaku Ryoho; 1982 Jan; 9(1):7-25. PubMed ID: 7184363
[No Abstract] [Full Text] [Related]
20. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
